嵌合型日本脑炎/登革2型病毒可保护小鼠免受登革病毒和日本脑炎病毒强毒株的攻击。 - Suppr

Suppr

超能文献

The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.

作者信息

Yang Jian, Yang Huiqiang, Li Zhushi, Lin Hua, Zhao Yu, Wang Wei, Tan Shuai, Zeng Xianwu, Li Yuhua

机构信息

Department of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.

Department of Microbiology and Immunology, North Sichuan Medical College, Nanchong, 637007, China.

出版信息

Protein Cell. 2017 Mar;8(3):225-229. doi: 10.1007/s13238-016-0363-5.

DOI:10.1007/s13238-016-0363-5

PMID:28124229

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5326627/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c4/5326627/31f88b3c2915/13238_2016_363_Fig1_HTML.jpg

相似文献

The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.嵌合型日本脑炎/登革2型病毒可保护小鼠免受登革病毒和日本脑炎病毒强毒株的攻击。

Protein Cell. 2017 Mar;8(3):225-229. doi: 10.1007/s13238-016-0363-5.

Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.基于非结构蛋白 1 抗体的表位阻断酶联免疫吸附试验用于区分人类乙型脑炎病毒和登革热病毒感染。

Jpn J Infect Dis. 2011;64(4):284-91.

Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.日本脑炎病毒非结构蛋白NS1抗体：基于单克隆抗体的间接酶联免疫吸附测定在区分感染与疫苗接种方面的潜在应用

Vaccine. 2001 Feb 8;19(13-14):1753-63. doi: 10.1016/s0264-410x(00)00391-1.

Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice.融合PCR产生的日本脑炎病毒/登革4病毒嵌合体在小鼠中表现出缺乏神经侵袭性、减弱的神经毒力以及双黄病毒免疫反应。

J Gen Virol. 2004 Sep;85(Pt 9):2503-2513. doi: 10.1099/vir.0.80120-0.

The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.四价登革热DNA疫苗对预先接触过日本脑炎或登革热病毒抗原的小鼠的免疫原性。

Asian Pac J Allergy Immunol. 2015 Sep;33(3):182-8. doi: 10.12932/AP0508.33.3.2015.

A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.一种基于日本脑炎病毒疫苗株SA14-14-2作为主干的新型登革病毒1型候选疫苗。

Arch Virol. 2016 Jun;161(6):1517-26. doi: 10.1007/s00705-016-2817-8. Epub 2016 Mar 15.

Vaccines aplenty.

Curr Opin Infect Dis. 2002 Oct;15(5):461-3. doi: 10.1097/00001432-200210000-00001.

Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.通过添加 JEV NS1 基因增强表达 prM/E 的嵌合疫苗的效用。

Vaccine. 2011 Oct 6;29(43):7444-55. doi: 10.1016/j.vaccine.2011.07.058. Epub 2011 Jul 26.

Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice.登革热和日本脑炎DNA疫苗在肌肉中产生抗原的证据及其与在小鼠中的免疫原性的关系。

Vaccine. 2003 Sep 8;21(25-26):3713-20. doi: 10.1016/s0264-410x(03)00376-1.

Development of new vaccines against dengue fever and Japanese encephalitis.新型登革热和日本脑炎疫苗的研发。

Intervirology. 2001;44(2-3):176-97. doi: 10.1159/000050045.

引用本文的文献

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.一种嵌合日本脑炎疫苗可预防致死性黄热病病毒感染而不诱导中和抗体。

mBio. 2020 Apr 7;11(2):e02494-19. doi: 10.1128/mBio.02494-19.

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14.嵌合日本脑炎病毒SA14/SA14-14-2毒力减弱，可抵御野生型毒株SA14的攻击。

Can J Infect Dis Med Microbiol. 2019 Mar 3;2019:9179308. doi: 10.1155/2019/9179308. eCollection 2019.

本文引用的文献

Arch Virol. 2016 Jun;161(6):1517-26. doi: 10.1007/s00705-016-2817-8. Epub 2016 Mar 15.

Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.以日本脑炎疫苗株SA14-14-2为骨架构建新型登革4型嵌合病毒并进行初步研究。

Virus Res. 2014 Oct 13;191:10-20. doi: 10.1016/j.virusres.2014.07.017. Epub 2014 Aug 1.

A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.一种嵌合登革病毒疫苗，以乙型脑炎病毒疫苗株 SA14-14-2 为骨架，在小鼠和非人灵长类动物中具有免疫原性和针对亲代病毒的保护作用。

J Virol. 2013 Dec;87(24):13694-705. doi: 10.1128/JVI.00931-13. Epub 2013 Oct 9.

Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.在小鼠模型中，抗 NS1 抗体与日本脑炎病毒的保护性免疫有关。

Virol J. 2012 Jul 24;9:135. doi: 10.1186/1743-422X-9-135.

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.日本脑炎减毒活疫苗病毒 SA14-14-2 的表型和基因型特征及其稳定性。

Vaccine. 2010 May 7;28(21):3635-41. doi: 10.1016/j.vaccine.2010.02.105. Epub 2010 Mar 11.

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.rDEN4Delta30-200,201的I期临床评估：一种旨在降低肝毒性的登革热4型减毒活疫苗候选株

Am J Trop Med Hyg. 2008 Nov;79(5):678-84.

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.rDEN4delta30是一种4型登革热减毒活疫苗候选株，在健康成年志愿者中安全、具有免疫原性且传染性很强。

J Infect Dis. 2005 Mar 1;191(5):710-8. doi: 10.1086/427780. Epub 2005 Jan 27.

J Gen Virol. 2004 Sep;85(Pt 9):2503-2513. doi: 10.1099/vir.0.80120-0.

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.嵌合黄热病-登革热病毒四价疫苗制剂在非人灵长类动物中的安全性和有效性。

J Virol. 2004 May;78(9):4761-75. doi: 10.1128/jvi.78.9.4761-4775.2004.

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.黄热病毒/登革2型病毒和黄热病毒/登革4型病毒嵌合体：在小鼠模型中的生物学特性、免疫原性及对登革脑炎的保护作用

J Virol. 2003 Mar;77(6):3655-68. doi: 10.1128/jvi.77.6.3655-3668.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验